Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 7/20 | 0.49 |
| ▸ | PTGS2 | P35354 | 4/20 | 0.49 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.45 |
| ▸ | PPARA | Q07869 | 1/20 | 0.43 |
| ▸ | ELANE | P08246 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9814058 | 0.83 | ALOX5 (0.61) | ALOX5PTGS2SLC2A1PPARAELANE | |
| SCHEMBL9814049 | 0.81 | ALOX5 (0.59) | ALOX5PTGS2SLC2A1PPARAELANE | |
| SCHEMBL9814061 | 0.81 | ALOX5 (0.59) | ALOX5PTGS2SLC2A1PPARAELANE | |
| SCHEMBL9814043 | 0.81 | ALOX5 (0.59) | ALOX5PTGS2SLC2A1PPARAELANE | |
| SCHEMBL23844202 | 0.81 | ALOX5 (0.51) | ALOX5PTGS2SLC2A1PPARAELANE | |
| SCHEMBL31539026 | 0.81 | ALOX5 (0.44) | ALOX5PTGS2SLC2A1PPARAELANE | |
| SCHEMBL10946460 | 0.80 | KCNH2 (0.39) | ALOX5PTGS2SMN1; SMN2 | |
| SCHEMBL6898660 | 0.77 | ALOX5 (0.53) | ALOX5PTGS2SLC2A1PPARAELANE | |
| SCHEMBL27916839 | 0.77 | PTGS2 (0.68) | ALOX5PTGS2SLC2A1PPARAELANE | |
| SCHEMBL7044011 | 0.76 | ALOX5 (0.61) | ALOX5PTGS2SLC2A1PPARAELANE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4575543-A | Low viscosity epoxy and phenoxy resins | THE DOW CHEMICAL COMPANY (US) | 1986-03-11 | — | — | US | disclosed |